Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Oxford University doctors and scientists are performing the second phase of clinical studies of an experimental Ebola vaccine regimen. Professors Andrew Pollard affiliated with the Jenner Institute is the Director of the Oxford Vaccine Group.